These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18618278)

  • 1. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Leitzmann MF; Ahn J; Albanes D; Hsing AW; Schatzkin A; Chang SC; Huang WY; Weiss JM; Danforth KN; Grubb RL; Andriole GL;
    Cancer Causes Control; 2008 Dec; 19(10):1267-76. PubMed ID: 18618278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of dietary alpha-linolenic acid and the risk of prostate cancer (United States).
    Koralek DO; Peters U; Andriole G; Reding D; Kirsh V; Subar A; Schatzkin A; Hayes R; Leitzmann MF
    Cancer Causes Control; 2006 Aug; 17(6):783-91. PubMed ID: 16783606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
    Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
    J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
    Andriole GL; Crawford ED; Grubb RL; Buys SS; Chia D; Church TR; Fouad MN; Isaacs C; Kvale PA; Reding DJ; Weissfeld JL; Yokochi LA; O'Brien B; Ragard LR; Clapp JD; Rathmell JM; Riley TL; Hsing AW; Izmirlian G; Pinsky PF; Kramer BS; Miller AB; Gohagan JK; Prorok PC;
    J Natl Cancer Inst; 2012 Jan; 104(2):125-32. PubMed ID: 22228146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial.
    Pinsky PF; Miller E; Prorok P; Grubb R; Crawford ED; Andriole G
    BJU Int; 2019 May; 123(5):854-860. PubMed ID: 30288918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.
    Kelly SP; Graubard BI; Andreotti G; Younes N; Cleary SD; Cook MB
    J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Digital Rectal Examination as an Adjunct to Prostate Specific Antigen in the Detection of Clinically Significant Prostate Cancer.
    Halpern JA; Oromendia C; Shoag JE; Mittal S; Cosiano MF; Ballman KV; Vickers AJ; Hu JC
    J Urol; 2018 Apr; 199(4):947-953. PubMed ID: 29061540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of fruit and vegetable intake and risk of prostate cancer.
    Kirsh VA; Peters U; Mayne ST; Subar AF; Chatterjee N; Johnson CC; Hayes RB;
    J Natl Cancer Inst; 2007 Aug; 99(15):1200-9. PubMed ID: 17652276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm.
    Halpern JA; Shoag JE; Mittal S; Oromendia C; Ballman KV; Hershman DL; Wright JD; Shih YT; Nguyen PL; Hu JC
    J Urol; 2017 Feb; 197(2):363-368. PubMed ID: 27569432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
    Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Pinsky PF; Black A; Parnes HL; Grubb R; David Crawford E; Miller A; Reding D; Andriole G
    Cancer Epidemiol; 2012 Dec; 36(6):e401-6. PubMed ID: 23000116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL.
    Fukushima H; Masuda H; Kawakami S; Ito M; Sakura M; Numao N; Koga F; Saito K; Fujii Y; Yamamoto S; Yonese J; Fukui I; Kihara K
    Urology; 2012 Jun; 79(6):1329-34. PubMed ID: 22656412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men.
    Dankner R; Boffetta P; Keinan-Boker L; Balicer RD; Berlin A; Olmer L; Murad H; Silverman B; Hoshen M; Freedman LS
    Diabetologia; 2016 Aug; 59(8):1683-91. PubMed ID: 27189066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and prostate cancer risk in the Carotene and Retinol Efficacy Trial.
    Bonn SE; Barnett MJ; Thornquist M; Goodman G; Neuhouser ML
    Eur J Cancer Prev; 2019 May; 28(3):212-219. PubMed ID: 29521683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Schenk JM; Riboli E; Chatterjee N; Leitzmann MF; Ahn J; Albanes D; Reding DJ; Wang Y; Friesen MD; Hayes RB; Peters U
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1227-31. PubMed ID: 19336558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Zhou CK; Pfeiffer RM; Cleary SD; Hoffman HJ; Levine PH; Chu LW; Hsing AW; Cook MB
    J Clin Oncol; 2015 Feb; 33(5):419-25. PubMed ID: 25225425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.
    Lacey JV; Kreimer AR; Buys SS; Marcus PM; Chang SC; Leitzmann MF; Hoover RN; Prorok PC; Berg CD; Hartge P;
    BMC Cancer; 2009 Mar; 9():84. PubMed ID: 19292893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation of Prostate-specific Antigen Value in Men and Risk of High-grade Prostate Cancer: Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Study.
    Boniol M; Autier P; Perrin P; Boyle P
    Urology; 2015 May; 85(5):1117-1122. PubMed ID: 25917734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the relationship between diabetes and prostate cancer through changes in screening guidelines.
    Miller EA; Pinsky PF
    Cancer Causes Control; 2020 Dec; 31(12):1105-1113. PubMed ID: 32970300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.